FDA adds drug to compounding lists; recalls hand sanitizers with wood alcohol
Food and Drug Administration this week added dexamethasone sodium phosphate to its lists for temporary compounding by outsourcing facilities and pharmacy compounders during the COVID-19 emergency. Drugs on these lists are intended to address shortages and increase access in the treatment of COVID-19 patients. FDA also this week announced voluntary recalls of two hand sanitizers due to the potential presence of methanol, also known as wood alcohol. Both AAA Cosmética, S.A. de C.V. and 4e Brands North America said they have not received complaints about the products.
Related News Articles
Headline
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…